These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6506619)

  • 21. Increased urinary excretion of angiotensin converting enzyme in patients with renal diseases.
    Kato I; Takada Y; Nishimura K; Hiwada K; Kokubu T
    J Clin Chem Clin Biochem; 1982 Jul; 20(7):473-6. PubMed ID: 6290590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Membranous glomerulonephritis in systemic lupus erythematosus. Clinical and histological study of 20 cases].
    Ferrario F; Bertoli S; Banfi G; Messina M; Mazzucco G; Guerra L; Barbiano Di Belgioioso G; Bucci A
    Minerva Nefrol; 1980; 27(4):549-53. PubMed ID: 7019770
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV; Sokolovskaia IV; Gonchar NA
    Ter Arkh; 1983; 55(6):39-41. PubMed ID: 6612619
    [No Abstract]   [Full Text] [Related]  

  • 24. [Urinary lactate dehydrogenase in kidney diseases. I. Lactate dehydrogenase in glomerulonephritides and nephrotic syndromes].
    Mojzís A
    Vnitr Lek; 1970 Sep; 16(9):862-7. PubMed ID: 5456350
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical aspects of combined kidney diseases (glomerulonephritis and pyelonephritis)].
    Volgina GV
    Klin Med (Mosk); 1981 Jul; 59(7):63-8. PubMed ID: 7278101
    [No Abstract]   [Full Text] [Related]  

  • 26. [Features of lipid peroxidation in the blood of patients with chronic glomerulonephritis at the stage of renal dysfunction in the presence of nephrotic syndrome].
    Tugusheva FA; Kulikova AI; Zubina IM
    Vopr Med Khim; 1993; 39(3):18-21. PubMed ID: 8333180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
    Kolesnik NA; Dudar' IA; Velichko MB
    Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The cytochemical characteristics of the epithelium of the proximal nephron and of the endothelium of the peritubular capillaries and kidney functional status in chronic glomerulonephritis patients].
    Kaiukov IG; Klechikov VZ; Vyrikov KA; Nikogosian IuA; Abissova NA
    Urol Nefrol (Mosk); 1993; (5):36-9. PubMed ID: 8310583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases.
    Danielsen H; Kornerup HJ; Olsen S; Posborg V
    Clin Nephrol; 1983 Jun; 19(6):284-7. PubMed ID: 6872365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical properties and pathophysiological significance of angiotensin converting enzyme in human urine].
    Kato I
    Nihon Jinzo Gakkai Shi; 1983 Mar; 25(3):339-49. PubMed ID: 6310188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Plasma benzylamine oxidase activity. IV. Children with the nephrotic syndrome].
    Dal Pozzo D; Tazzari R; Toschi M; Corsini F
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1942-4. PubMed ID: 7459105
    [No Abstract]   [Full Text] [Related]  

  • 32. [Morphofunctional changes in the upper digestive canal in chronic glomerulonephritis].
    Gorgol' VA; Pyrig LA; Anishchenko VM; Blagodarov VN; Musienko LP
    Vrach Delo; 1982 Jul; (7):64-6. PubMed ID: 7135909
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of pathogenetic therapy on karyographic indices in chronic glomerulonephritis].
    Pluzhnik EG
    Vrach Delo; 1982 Sep; (9):40-1. PubMed ID: 7179910
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceedings: Physiopathological significance and clinical use of urinary enzymes].
    Bonini PA; Guarnieri GF; De Nadai-Frank A; Ceriotti G
    Quad Sclavo Diagn; 1973 Mar; 9(1):419-41. PubMed ID: 4788722
    [No Abstract]   [Full Text] [Related]  

  • 35. A follow up study of adult nephrotic syndrome in Nigerians: outcome and predictors of endstage renal failure.
    Ojogwu LI; Ukoli FA
    Afr J Med Med Sci; 1993 Jun; 22(2):43-50. PubMed ID: 7839896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical significance of renal functional reserve].
    Zverev KV; Kutyrina IM; Gersimenko OI
    Klin Med (Mosk); 1995; 73(3):99-102. PubMed ID: 8577129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pregnancy in women with nephrotic syndrome in chronic glomerulonephritis].
    Wielgosz A; Zdrojewski Z
    Pol Tyg Lek; 1984 Oct 1-8; 39(40-41):1309-11. PubMed ID: 6514599
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
    Ishikawa H; Honjo A; Hayashi M; Hamaguchi T; Morita T; Shindo T; Tetsutani T; Yamamoto T; Okubo H; Oka G
    Arzneimittelforschung; 1982; 32(3):301-9. PubMed ID: 7200790
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic renal failure in India.
    Sakhuja V; Jha V; Ghosh AK; Ahmed S; Saha TK
    Nephrol Dial Transplant; 1994; 9(7):871-2. PubMed ID: 7970132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renal incapacity to utilize glutamine for ammonia production in chronic renal insufficiency].
    Tizianello A; De Ferrari G; Gurreri G; Bertocchi I; Garibotto G
    Minerva Nefrol; 1975; 22(2-3):138-47. PubMed ID: 1226249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.